Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ilex MedicalXTAE:ILX +0.89%62 Buyback Yield % is 0.00 as of Aug. 01, 2026. GuruFocus rates XTAE:ILX with a GF Score™ of 62/100 and a GF Value™ of ₪63.57 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 347 Medical Devices & Instruments companies, Ilex Medical ranks worse than 288184.15% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Ilex Medical's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTAE:ILX vs ABT, SYK, MDT: Buyback Yield % Comparison
For the Medical Devices subindustry, Ilex Medical's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ilex Medical Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ilex Medical's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Ilex Medical's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ilex Medical (XTAE:ILX) has a Buyback Yield % of 0.00 as of Aug. 01, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Ilex Medical and its competitors. Over the past decade, Ilex Medical's Buyback Yield % has ranged from 0.32 to 0.87. According to the industry distribution chart, Ilex Medical ranks #999999 out of 347 companies in the Medical Devices & Instruments industry.
Is Ilex Medical's Buyback Yield % too high?
Ilex Medical's current Buyback Yield % is 0.00. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 0.87. Based on the distribution chart, Ilex Medical ranks #999999 out of 347 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Ilex Medical has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ilex Medical's Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ilex Medical ranks #999999 out of 347 companies for Buyback Yield %. This places Ilex Medical in the lower half of its industry. Historically, Ilex Medical's own Buyback Yield % has ranged from 0.32 to 0.87 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Ilex Medical and its competitors. Ilex Medical's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ilex Medical stock overvalued right now?
Based on GuruFocus' analysis, Ilex Medical (XTAE:ILX) is currently considered Modestly Undervalued. The stock's GF Value™ is ₪63.57, compared to a current price of ₪49.82 — trading 21.6% below its estimated fair value. The current Buyback Yield % is 0.00. Ilex Medical's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Ilex Medical (XTAE:ILX), the current Buyback Yield % is 0.00 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ilex Medical (XTAE:ILX) Overvalued in 2026?
Based on GuruFocus' analysis, Ilex Medical stock appears to be undervalued.
The current stock price of ₪49.82 is trading 21.6% below its estimated GF Value™ of ₪63.57.
GuruFocus considers Ilex Medical to be Modestly Undervalued.
Key valuation signals for XTAE:ILX:
Buyback Yield %: 0.00
GF Value™: ₪63.57 vs. price of ₪49.82 (21.6% below fair value)
No single metric tells the full story. See the XTAE:ILX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ilex Medical Ltd is an Israel based company engages in the marketing and distribution of diagnostic products and other medical laboratory information systems. It offers in-vitro diagnostic equipment, reagents, laboratory management software, blood bank diagnostic kits, and diagnostic support services to the healthcare sector in Israel.
62GF Score
Get the complete analysis for XTAE:ILX
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:ILX has been successfully added to your 
